Ubisoft Entertainment : Close to a support level
Entry price | Target | Stop-loss | Potential |
---|
€69.7 |
€78 |
€64 |
+11.91% |
---|
Ubisoft Entertainment shares have been fluctuating horizontalally for several weeks. As the share price approaches the lower bounds, a buying opportunity could arise.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths● Share prices are approaching a strong support area in daily data, which offers good timing for investors.
● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
● Thanks to a sound financial situation, the firm has significant leeway for investment.
● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
● The tendency within the weekly time frame is positive above the technical support level at 61.4 EUR
Weaknesses● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.